Meeting
2021 Gastrointestinal Cancers Symposium
Projected 30-day out-of-pocket and total spending on pancreatic enzyme replacement therapy under Medicare Part D.
Authors
Arjun Gupta
University of Texas Southwestern Medical Center, Dallas, TX
Arjun Gupta , Naveen Premnath , Muhammad Shaalan Beg , Rohan Khera , Stacie Dusetzina
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Pancreatic Cancer
Track
Pancreatic Cancer
Sub Track
Symptoms, Toxicities, and Whole-Person Care
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 401)
DOI
10.1200/JCO.2021.39.3_suppl.401
Abstract #
401
Poster Bd #
Online Only
Abstract Disclosures
Funded by Conquer Cancer
Similar Posters
Poster
2023 ASCO Quality Care Symposium
The high cost of supplements, complementary therapy, and alternative medicine in patients with breast cancer.
First Author: Kaitlyn Lapen
First Author: Nivedita Arora
Poster
2016 ASCO Annual Meeting
Rising financial burden of targeted oral anticancer medications on the Medicare Part D program and its beneficiaries.
First Author: Ya-Chen T. Shih
Poster
2015 ASCO Annual Meeting
Out-of-pocket cost trends for Medicare patients with newly diagnosed cancer.
First Author: Amol Narang